Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

October 7, 2021
Health equity and social justice are critical drivers of quality cancer care, and practice-based solutions are needed to reduce barriers and improve health outcomes. There is a crucial need for psychosocial and supportive care services to address the differences in social and economic resources and in timely access to high-quality health care.
Pavan Kumar Tenneti Venkata, MD, et al., Levine Cancer Institute, Charlotte, NC View Poster
Dan Margalski, DO, et al., Wake Forest School of Medicine, Winston-Salem, NC View Poster
Anne Wofford, MD, et al., Wake Forest School of Medicine, Winston-Salem, NC View Poster
Andrew Benefield, MD, et al., Wake Forest School of Medicine, Winston-Salem, NC View Poster
Heather Wolfe, MD, et al., Duke University School of Medicine, Durham, NC View Poster
James Isaacs, MD, et al., Duke University School of Medicine, Durham, NC View Poster
Sukriti Kamboj, MD, et al., East Carolina University, Greenville, NC View Poster
Annum Faisal, MD, et al., East Carolina University, Greenville, NC View Poster
Joanna A. Young, DO, et al., Levine Cancer Institute, Charlotte, NC View Poster
Christopher R. Pallas, MD, et al., Levine Cancer Institute, Charlotte, NC View Poster
Jennifer Morgan, MD, et al., University of North Carolina School of Medicine, Chapel Hill, NC View Poster
Christopher Jensen, MD, et al., University of North Carolina School of Medicine, Chapel Hill, NC View Poster
Slide 1 INTRODUCTION RESULTS RESULTS DISCUSSION ADAMTS13 Inhibitor as a Marker for Recurrence of Acquired Thrombotic Thrombocytopenic Purpura Annum Faisal, MD1,2, Darla Liles, MD1, Yara Park, MD3* and Meera Sridharan, MD, PhD4 1Division of Hematology–Oncology, East Carolina University, Greenville, NC; 2on behalf of the USTMA Consortium, Greenville, NC; 3University of North Carolina …
PowerPoint Presentation
Slide 1 Preliminary Studies • Retrospective cohort study aimed at examining the prevalence of osteoporosis, osteopenia, screening of bone mineral density by DXA, use of therapeutics for osteoporosis or osteopenia, and cumulative incidence of fragility fractures. • Methods: • Obtained a nationally representative 5% sample of Medicare files from CMS between 2010 – 2015. • Defined …
PowerPoint Presentation Andrew Benefield, MD, Benjamin Rush, MD, Jimmy Ruiz, MD, Mark Geraci, PharmD, Michael Goodman, MD W. G. (Bill) Hefner VA Medical Center – Salisbury, NC Immunotherapy Experience in Nonagenarian Veterans with Cancer Purpose of the project: The purpose of this project was to describe the experience of treating veterans >/= 90 years of age with immune …
Main finding goes here, translated into plain English. Emphasize the important words. Background: • Median overall survival (OS) in landmark trials evaluating immunotherapy (IO) as compared to chemotherapy (chemo) in patients with metastatic non-small cell lung cancer (mNSCLC) ranged from 17-26 months1-3 • Observed median OS in “real-world” studies ranges from 8-12 months4-5 • …
PowerPoint Presentation PCSK9 IMPACTS DENDRITIC CELL MATURATION AND IMPAIRS ANTIGEN UPTAKE James Isaacs MD, Liliana Lyniv MS, Scott Antonia MD, PhD Duke University • Previous work published by the lab of Dr. Chuan-Yuan Li at Duke University has shown that the lipid metabolism protein PCSK9 is secreted by tumors and can contribute to an immune excluded microenvironment in …
Anne Wofford, MD; Elizabeth Rogers, PharmD; Brandi Anders, PHarmD, BCOPS, CPP; Scott Isom, PhD; LeAnne Kennedy, PHarmD, BCOP, CPP, FHOPA; Dianna Howard, MD; Mary Seegars, MD Wake Forest Baptist Comprehensive Cancer Center; Stem Cell Transplant and Cellular Therapy Program, Winston-Salem, NC Anne Wofford, MD; Elizabeth Rogers, PharmD; Brandi Anders, PharmD, BCOPS, CPP; Scott Isom, PhD; LeAnne …